Markets & news

ONESOURCE SPECIALTY PHARMA LTD.

NSE : ONESOURCEBSE : 544292ISIN CODE : INE013P01021Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 182605.11 Face Value (Rs.) : 1 House : Private
BSECurrent Price (Rs.) 1592.40Change (Rs.)46.95 (+3.04 %)
PREV CLOSE (Rs.) 1545.45
OPEN PRICE (Rs.) 1527.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 36225
TODAY'S LOW / HIGH (Rs.)1527.05 1624.00
52 WK LOW / HIGH (Rs.)1075 1924
NSECurrent Price (Rs.) 1592.20Change (Rs.)50.3 (+3.26 %)
PREV CLOSE( Rs. ) 1541.90
OPEN PRICE (Rs.) 1548.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1592.20 (16)
VOLUME 919086
TODAY'S LOW / HIGH(Rs.) 1530.00 1624.70
52 WK LOW / HIGH (Rs.)1057 1925
GO

Financial Ratios

Particulars
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Operational & Financial Ratios
 
 
 
 
 
   Earnings Per Share (Rs)
-6.44  
-1.57  
-97.55  
-199.46  
-76.14  
   CEPS(Rs)
17.91  
22.42  
-72.17  
-87.27  
-15.39  
   DPS(Rs)
0.00  
0.00  
0.00  
0.00  
0.00  
   Book NAV/Share(Rs)
508.17  
512.83  
96.71  
194.39  
333.49  
   Tax Rate(%)
19.75  
74.23  
0.00  
0.00  
0.11  
Margin Ratios
 
 
 
 
 
   Core EBITDA Margin(%)
19.01  
32.10  
-51.33  
-415.06  
-3.13  
   EBIT Margin(%)
2.11  
6.87  
-160.69  
-950.82  
-41.67  
   Pre Tax Margin(%)
-6.41  
-4.64  
-212.71  
-1073.63  
-77.94  
   PAT Margin (%)
-5.14  
-1.20  
-212.71  
-1073.63  
-77.86  
   Cash Profit Margin (%)
14.31  
17.76  
-168.34  
-903.98  
-36.45  
Performance Ratios
 
 
 
 
 
   ROA(%)
-0.94  
-0.39  
-22.05  
-18.68  
-4.09  
   ROE(%)
-1.26  
-0.55  
-62.66  
-46.39  
-9.86  
   ROCE(%)
0.44  
2.61  
-21.41  
-19.43  
-2.46  
   Asset Turnover(x)
0.18  
0.33  
0.10  
0.02  
0.05  
   Sales/Fixed Asset(x)
0.21  
0.37  
0.12  
0.03  
0.09  
   Working Capital/Sales(x)
-89.50  
-52.77  
-0.38  
-0.06  
-0.43  
Efficiency Ratios
 
 
 
 
 
   Fixed Capital/Sales(x)
4.71  
2.70  
8.06  
39.06  
10.86  
   Receivable days
140.79  
59.60  
62.70  
129.47  
67.33  
   Inventory Days
75.94  
21.38  
153.27  
1926.33  
784.45  
   Payable days
225.76  
107.62  
455.14  
1407.02  
NA  
Valuation Parameters
 
 
 
 
 
   PER(x)
0.00  
0.00  
0.00  
0.00  
0.00  
   PCE(x)
82.21  
77.95  
0.00  
0.00  
0.00  
   Price/Book(x)
2.90  
3.41  
0.00  
0.00  
0.00  
   Yield(%)
0.00  
0.00  
NA  
NA  
NA  
   EV/Net Sales(x)
12.70  
14.17  
2.94  
19.65  
7.70  
   EV/Core EBITDA(x)
56.55  
42.30  
-6.02  
-4.82  
-2930.49  
   EV/EBIT(x)
597.37  
206.27  
-1.83  
-2.07  
-18.49  
   EV/CE(x)
2.54  
3.08  
0.53  
0.47  
0.46  
   M Cap / Sales
11.87  
13.84  
0.00  
0.00  
0.00  
Growth Ratio
 
 
 
 
 
   Net Sales Growth(%)
-1.61  
740.43  
344.07  
-69.80  
0.00  
   Core EBITDA Growth(%)
-34.04  
676.08  
46.82  
0.00  
0.00  
   EBIT Growth(%)
-69.55  
135.93  
24.95  
-589.20  
0.00  
   PAT Growth(%)
-327.08  
95.27  
12.02  
-316.48  
0.00  
   EPS Growth(%)
-310.00  
98.39  
51.09  
-161.96  
0.00  
Financial Stability Ratios
 
 
 
 
 
   Total Debt/Equity(x)
0.22  
0.13  
1.45  
1.07  
1.14  
   Current Ratio(x)
0.99  
0.98  
0.28  
0.26  
0.63  
   Quick Ratio(x)
0.69  
0.83  
0.26  
0.11  
0.29  
   Interest Cover(x)
0.25  
0.60  
-3.09  
-7.74  
-1.15  
   Total Debt/Mcap(x)
0.08  
0.04  
NA  
NA  
NA  
BACK TO TOP